Immunogenicity and pharmacokinetics of guselkumab among patients with moderate‐to‐severe psoriasis in VOYAGE‐1 and VOYAGE‐2-Reference-Cited by-同舟云学术

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate‐to‐severe psoriasis in VOYAGE‐1 and VOYAGE‐2

Published:2023-07-28 Issue:12 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Armstrong A.¹,Eyerich K.²^ORCID,Conrad C.³^ORCID,Zhu Y.⁴,Yang Y.‐W.⁵,Miller M.⁴,You Y.⁴,Shen Y.‐K.⁴,Foley P.⁶,Griffiths C. E. M.⁷⁸^ORCID,Strober B.⁹¹⁰^ORCID

Affiliation:

1. Keck School of Medicine University of Southern California Los Angeles California USA

2. University of Freiburg Baden‐Württemberg Germany

3. Lausanne University Hospital CHUV Lausanne Switzerland

4. Janssen Research & Development, LLC Spring House Pennsylvania USA

5. Immunology Global Medical Affairs Janssen Pharmaceutical Companies of Johnson & Johnson Horsham Pennsylvania USA

6. The University of Melbourne St. Vincent's Hospital Melbourne and Probity Medical Research Skin Health Institute Carlton Victoria Australia

7. Dermatology Centre NIHR Manchester Biomedical Research Centre University of Manchester Manchester UK

8. King's College Hospital King's College London London UK

9. Yale University New Haven Connecticut USA

10. Central Connecticut Dermatology Research Cromwell Connecticut USA

Funder

Janssen Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19309

Reference11 articles.

1. Impact of immunogenicity on response to anti-TNF therapy in moderate-to-severe plaque psoriasis: results of the PREDIR study

2. Immunogenicity of engineered antibodies

3. Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12